The majority of patients with high-grade serous ovarian cancer (HGSOC) initially respond to chemotherapy; however, most will develop chemotherapy resistance. Gene signatures may change with the development of chemotherapy resistance in this population, which is important as it may lead to tailored t...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!